OSTARINE
associated with 2 other trademarks
pharmaceutical preparations for use in the prevention or treatment of any disease related to muscle wasting or androgen testosterone deficiency, inclu...

Words that describe this trademark:

prevention treatment  any disease  pharmaceutical preparations  androgen testosterone  disease related  muscle wasting  related  treatment  wasting  preparations 

Serial Number:

85332057

Mark:

OSTARINE

Status:

Cancelled-Section 8

Status Date:

09-09-2022

Filing Date:

Registration Number:

4104772

Registration Date:

02-28-2012

Goods and Services:

pharmaceutical preparations for use in the prevention or treatment of any disease related to muscle wasting or androgen testosterone deficiency, including but not limited to cancer, kidney disease, HIV infection, hypogonadism, cardiovascular disease, pulmonary disease, atherosclerosis, osteoporosis, bone disorders, dry eye, meibomian gland disease, appetite disorders, frailty, metabolic syndrome, obesity, wasting disorders, depression or sexual dysfunction

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

12-13-2011

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

PEARL COHEN ZEDEK LATZER BARATZ LLP

Correspondent Name:

Recent Trademark filings by this company